BioLife Solutions (BLFS) Tops Q4 EPS by 23c ; Offers Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $27.19 -2.65%
Revenue Growth %: +8.2%
Financial Fact:
Operating loss: -1.14M
Today's EPS Names:
CRMT, PKE, HELE, More
Revenue Growth %: +8.2%
Financial Fact:
Operating loss: -1.14M
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of $0.22, $0.23 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $24.05 million.
GUIDANCE:
BioLife Solutions sees FY2026 revenue of $112.5-115 million, versus the consensus of $110.8 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
- Zhipu AI prices HK offering at HK$1,588/share - Reuters
- First Majestic raises 2026 output guidance after Q2 silver, gold gains
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
